Last updated: January 30, 2024
Sponsor: Arizona State University
Overall Status: Completed
Phase
N/A
Condition
Metabolic Disorders
Inflammation
Diabetes Prevention
Treatment
Vinegar pill
Liquid vinegar
Clinical Study ID
NCT05698381
STUDY00017204
Ages 18-40 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- healthy
- non-smoker
- free of chronic disease by self-report
- able to speak, read, and understand English
- able to consent.
- BMI ≥ 25 and ≤ 35
Exclusion
Exclusion Criteria:
- adherence to specific diets for weight loss
- vegetarian
- report GERD or regular heartburn
- unwilling to consume vinegar daily for 4 weeks
- pregnant or lactating women
- recreational drug use, alcohol intake above recommendations (1 drink/day for women, 2drinks/day for men - or none)
- competitive level physical training (e.g., physical activity above recommendations asset by the Physical Activity Guidelines for Americans)
- scoring 1 or higher on question 9 of the PHQ-9 questionnaire.
Study Design
Total Participants: 36
Treatment Group(s): 2
Primary Treatment: Vinegar pill
Phase:
Study Start date:
February 01, 2023
Estimated Completion Date:
August 15, 2023
Study Description
Connect with a study center
850 PBC
Phoenix, Arizona 85004
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.